These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 24267869)

  • 1. Lifestyle interventions for diabetes mellitus type 2 prevention.
    Sagarra R; Costa B; Cabré JJ; Solà-Morales O; Barrio F;
    Rev Clin Esp (Barc); 2014 Mar; 214(2):59-68. PubMed ID: 24267869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and design of the PREDICE project: cost-effectiveness of type 2 diabetes prevention among high-risk Spanish individuals following lifestyle intervention in real-life primary care setting.
    Costa B; Cabré JJ; Sagarra R; Solà-Morales O; Barrio F; Piñol JL; Cos X; Bolíbar B; Castell C; Kissimova-Skarbek K; Tuomilehto J;
    BMC Public Health; 2011 Aug; 11():623. PubMed ID: 21831332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delaying progression to type 2 diabetes among high-risk Spanish individuals is feasible in real-life primary healthcare settings using intensive lifestyle intervention.
    Costa B; Barrio F; Cabré JJ; Piñol JL; Cos X; Solé C; Bolíbar B; Basora J; Castell C; Solà-Morales O; Salas-Salvadó J; Lindström J; Tuomilehto J;
    Diabetologia; 2012 May; 55(5):1319-28. PubMed ID: 22322921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of a lifestyle intervention in preventing Type 2 diabetes.
    Irvine L; Barton GR; Gasper AV; Murray N; Clark A; Scarpello T; Sampson M
    Int J Technol Assess Health Care; 2011 Oct; 27(4):275-82. PubMed ID: 22004767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of the DP-TRANSFERS project in Catalonia: A translational method to improve diabetes screening and prevention in primary care.
    Costa-Pinel B; Mestre-Miravet S; Barrio-Torrell F; Cabré-Vila JJ; Cos-Claramunt X; Aguilar-Sanz S; Solé-Brichs C; Castell-Abat C; Arija-Val V; Lindström J;
    PLoS One; 2018; 13(3):e0194005. PubMed ID: 29543842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost and clinical implications of diabetes prevention in an Australian setting: a long-term modeling analysis.
    Palmer AJ; Tucker DM
    Prim Care Diabetes; 2012 Jul; 6(2):109-21. PubMed ID: 22153888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained diabetes risk reduction after real life and primary health care setting implementation of the diabetes in Europe prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project.
    Gilis-Januszewska A; Lindström J; Tuomilehto J; Piwońska-Solska B; Topór-Mądry R; Szybiński Z; Peltonen M; Schwarz PE; Windak A; Hubalewska-Dydejczyk A
    BMC Public Health; 2017 Feb; 17(1):198. PubMed ID: 28202029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design.
    Sun X; Guo L; Shang H; Ren M; Wang Y; Huo D; Lei X; Wang H; Zhai J
    Trials; 2015 Nov; 16():496. PubMed ID: 26530718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective translation of a type-2 diabetes primary prevention programme into routine primary care: The PreDE cluster randomised clinical trial.
    Sanchez A; Silvestre C; Campo N; Grandes G;
    Diabetes Res Clin Pract; 2018 May; 139():32-42. PubMed ID: 29476888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lifestyle intervention to prevent diabetes in men and women with impaired glucose tolerance is cost-effective.
    Lindgren P; Lindström J; Tuomilehto J; Uusitupa M; Peltonen M; Jönsson B; de Faire U; Hellénius ML;
    Int J Technol Assess Health Care; 2007; 23(2):177-83. PubMed ID: 17493303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of type 2 diabetes by lifestyle intervention in an Australian primary health care setting: Greater Green Triangle (GGT) Diabetes Prevention Project.
    Laatikainen T; Dunbar JA; Chapman A; Kilkkinen A; Vartiainen E; Heistaro S; Philpot B; Absetz P; Bunker S; O'Neil A; Reddy P; Best JD; Janus ED
    BMC Public Health; 2007 Sep; 7():249. PubMed ID: 17877832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Family history of diabetes and effectiveness of lifestyle counselling on the cardio-metabolic risk profile in individuals at high risk of Type 2 diabetes: 1-year follow-up of the FIN-D2D project.
    Rautio N; Jokelainen J; Oksa H; Saaristo T; Peltonen M; Puolijoki H; Tuomilehto J; Vanhala M; Moilanen L; Uusitupa M; Keinänen-Kiukaanniemi S
    Diabet Med; 2012 Feb; 29(2):207-11. PubMed ID: 21781153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.
    Herman WH; Hoerger TJ; Brandle M; Hicks K; Sorensen S; Zhang P; Hamman RF; Ackermann RT; Engelgau MM; Ratner RE;
    Ann Intern Med; 2005 Mar; 142(5):323-32. PubMed ID: 15738451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Achievable cost saving and cost-effective thresholds for diabetes prevention lifestyle interventions in people aged 65 years and older: a single-payer perspective.
    Anderson JM
    J Acad Nutr Diet; 2012 Nov; 112(11):1747-54. PubMed ID: 23102174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants for the effectiveness of lifestyle intervention in the Finnish Diabetes Prevention Study.
    Lindström J; Peltonen M; Eriksson JG; Aunola S; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Uusitupa M; Tuomilehto J;
    Diabetes Care; 2008 May; 31(5):857-62. PubMed ID: 18252900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An active strategy to identify individuals eligible for type 2 diabetes prevention by lifestyle intervention in Dutch primary care: the APHRODITE study.
    Vermunt PW; Milder IE; Wielaard F; van Oers JA; Westert GP
    Fam Pract; 2010 Jun; 27(3):312-9. PubMed ID: 20089573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of a quality improvement collaborative focusing on patients with diabetes.
    Schouten LM; Niessen LW; van de Pas JW; Grol RP; Hulscher ME
    Med Care; 2010 Oct; 48(10):884-91. PubMed ID: 20808258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of a lifestyle intervention in high-risk individuals for diabetes in a low- and middle-income setting: Trial-based analysis of the Kerala Diabetes Prevention Program.
    Sathish T; Oldenburg B; Thankappan KR; Absetz P; Shaw JE; Tapp RJ; Zimmet PZ; Balachandran S; Shetty SS; Aziz Z; Mahal A
    BMC Med; 2020 Sep; 18(1):251. PubMed ID: 32883279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of the FINDRISC questionnaire to identify individuals with impaired glucose tolerance in Swedish primary care. A cross-sectional population-based study.
    Hellgren MI; Petzold M; Björkelund C; Wedel H; Jansson PA; Lindblad U
    Diabet Med; 2012 Dec; 29(12):1501-5. PubMed ID: 22443428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and Cost-Effectiveness of a Cluster-Randomized Prenatal Lifestyle Counseling Trial: A Seven-Year Follow-Up.
    Kolu P; Raitanen J; Puhkala J; Tuominen P; Husu P; Luoto R
    PLoS One; 2016; 11(12):e0167759. PubMed ID: 27936083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.